Protagonist Therapeutics Stock Price

-0.78 (-3.75%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.78 -3.75% 20.04 17:15:00
Close Price Low Price High Price Open Price Previous Close
20.04 19.88 20.985 20.92 20.82
Bid Price Ask Price Spread News
18.00 23.45 5.45 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,091 165,153 $ 20.14 $ 3,325,726 401,395 4.47 - 23.25
Last Trade Time Type Quantity Stock Price Currency
16:03:40 formt 3,227 $ 20.04 USD

Protagonist Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 737.62M 36.81M 32.21M $ 231.00k $ - -2.99 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Protagonist Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTGX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week21.3222.5519.8821.60287,371-1.28-6.0%
1 Month21.4822.796519.0420.92347,399-1.44-6.7%
3 Months15.5823.2514.1620.09350,9124.4628.63%
6 Months7.0423.256.1316.27702,29613.00184.66%
1 Year11.7423.254.4713.23560,4388.3070.7%
3 Years16.4923.974.4712.37317,0473.5521.53%
5 Years12.0026.35984.4712.58250,4048.0467.0%

Protagonist Therapeutics Description

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.